Atlantic Healthcare closes $24 million financing with founders of SalixPharmaceuticals and Clinigen Group, and LDC


Investment secures funds to complete pivotal Phase 3 trial of alicaforsen in pouchitis and file for regulatory approval in North America and Europe Dr Lorin K Johnson, Scientific Founder of Salix Pharmaceutical, joins Board and Leadership team…

Read More

Atlantic Healthcare starts pivotal Phase 3 trial of Alicaforsen to treatInflammatory Bowel Disease Pouchitis


Study of fast-tracked and orphan designated alicaforsen is the largest ever in pouchitis, and aims to confirm efficacy in antibiotic refractory patientsCambridge, UK, 11 February 2016. Atlantic Healthcare plc, ("Atlantic Healthcare") an…

Read More